Chanan-Khan Asher has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 60000 shares of Cellectar Biosciences, Inc. ($CLRB) on February 14, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 14, 2025 | Cellectar Biosciences, Inc. | $CLRB | Chanan-Khan Asher | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 1,238,125 | 9999.99% | 4.85% |
| June 14, 2024 | Cellectar Biosciences, Inc. | $CLRB | Chanan-Khan Asher | Director | A | Stock option (right to buy) | 60000 | $0.00 | 60,000.0000 | 29,346,679 | 9999.99% | 0.20% |
| June 28, 2023 | Cellectar Biosciences, Inc. | $CLRB | Chanan-Khan Asher | Director | A | Stock option (right to buy) | 25000 | $0.00 | 40,600.0000 | 11,261,217 | 160.26% | 0.22% |